Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)

Q: What does CUSIP 30050B101 represent in this 13F holders report?

CUSIP 30050B101 is the security identifier for EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in Q2 2023?

216 institutional investors reported EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 30050B101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Class A Common Stock, par value $0.01 per share
Shares outstanding: 112,318,617
Total 13F shares: 117,663,348
Share change: +5,826,584
Total reported value: $3,553,501,314
Put/Call ratio: 446%
Price per share: $30.30
Number of holders: 216
Value change: +$168,830,769
Number of buys: 103
Number of sells: 116

Quarterly Holders Quick Answers

What is CUSIP 30050B101?
CUSIP 30050B101 identifies EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 30050B101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	13%	14,641,699	$461,373,133	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	8.3%	9,320,669	$302,455,709	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	6.2%	6,928,258	$224,821,971	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	5%	5,560,550	$180,439,519	—	31 Mar 2023	13F
Rock Springs Capital Management LP	13F	Company	3.4%	3,803,500	$123,423,575	—	31 Mar 2023	13F
Granahan Investment Management, LLC	13F	Company	3%	3,374,911	$109,515,862	—	31 Mar 2023	13F
Invesco Ltd.	13F	Company	3%	3,342,586	$108,466,915	—	31 Mar 2023	13F
ORBIMED ADVISORS LLC	13F	Company	2.6%	2,895,632	$93,963,258	—	31 Mar 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.2%	2,499,435	$81,106,666	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	2.2%	2,492,972	$80,895,225	—	31 Mar 2023	13F
BLAIR WILLIAM & CO/IL	13F	Company	2.1%	2,348,583	$76,211,518	—	31 Mar 2023	13F
LOOMIS SAYLES & CO L P	13F	Company	2%	2,278,827	$73,948,000	—	31 Mar 2023	13F
Engaged Capital LLC	13F	Company	2%	2,213,454	$71,826,582	—	31 Mar 2023	13F
Bellevue Group AG	13F	Company	2%	2,191,147	$71,102,720	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.8%	2,018,410	$65,497,000	—	31 Mar 2023	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.7%	1,902,755	$61,744,400	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	1.7%	1,876,520	$60,893,074	—	31 Mar 2023	13F
CREDIT SUISSE AG/	13F	Company	1.6%	1,801,598	$58,461,856	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	1,623,390	$52,679,028	—	31 Mar 2023	13F
Holocene Advisors, LP	13F	Company	1.4%	1,593,753	$51,717,285	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	1.4%	1,577,645	$51,194,581	—	31 Mar 2023	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	1.3%	1,457,143	$47,241,920	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	1.3%	1,435,480	$46,581,326	—	31 Mar 2023	13F
MACQUARIE GROUP LTD	13F	Company	1.2%	1,370,717	$44,480,000	—	31 Mar 2023	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	1.2%	1,351,105	$43,843,357	—	31 Mar 2023	13F
Greenhouse Funds LLLP	13F	Company	1.2%	1,339,179	$43,456,359	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	1.1%	1,239,136	$40,210,000	—	31 Mar 2023	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1%	1,164,164	$37,777,122	—	31 Mar 2023	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	1%	1,143,909	$37,119,847	—	31 Mar 2023	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.98%	1,099,256	$35,670,000	—	31 Mar 2023	13F
Iron Triangle Partners LP	13F	Company	0.89%	1,000,402	$32,463,045	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.87%	978,939	$31,766,571	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.86%	964,231	$31,289,297	—	31 Mar 2023	13F
NORGES BANK	13F	Company	0.76%	848,333	$27,528,406	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.75%	843,944	$27,387,000	—	31 Mar 2023	13F
SILVERCREST ASSET MANAGEMENT GROUP LLC	13F	Company	0.74%	834,955	$27,094,290	—	31 Mar 2023	13F
Hood River Capital Management LLC	13F	Company	0.74%	833,801	$27,057,000	—	31 Mar 2023	13F
TPG GP A, LLC	13F	Company	0.68%	763,140	$24,763,893	—	31 Mar 2023	13F
Frank J. Williams	3/4/5	Director	— mixed-class rows	903,126 mixed-class rows	$24,140,121	—	01 Jun 2023	3/4/5
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.65%	724,997	$23,526,152	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.59%	667,516	$21,660,894	—	31 Mar 2023	13F
FULLER & THALER ASSET MANAGEMENT, INC.	13F	Company	0.5%	560,895	$18,201,043	—	31 Mar 2023	13F
KORNITZER CAPITAL MANAGEMENT INC /KS	13F	Company	0.49%	549,071	$17,817,354	—	31 Mar 2023	13F
GABELLI FUNDS LLC	13F	Company	0.46%	520,500	$16,890,225	—	31 Mar 2023	13F
Summit Creek Advisors LLC	13F	Company	0.45%	504,105	$16,358,207	—	31 Mar 2023	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.44%	491,142	$15,937,558	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.44%	488,728	$15,859,224	—	31 Mar 2023	13F
GLENMEDE TRUST CO NA	13F	Company	0.43%	483,248	$15,681,397	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.39%	433,722	$14,074,279	—	31 Mar 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.36%	409,202	$13,278,605	—	31 Mar 2023	13F

Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q2 2023

As of 30 Jun 2023, Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) was held by 216 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 117,663,348 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, Rock Springs Capital Management LP, WELLINGTON MANAGEMENT GROUP LLP, Bellevue Group AG, Invesco Ltd., Granahan Investment Management, LLC, and ORBIMED ADVISORS LLC. This page lists 216 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

237

Q2 2023 holders

216

Holder diff

-21

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.